Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Melamed

Showing results (101-110 of 217) with videos related to

Pageof 22
Sort By:
Gynecologic Oncology|March 28, 2023
Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapyKirsten Jorgensen, Alexander Melamed, Chi-Fang Wu, et al.
Obstetrics and Gynecology|February 9, 2017
Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian CancerAllison Gockley, Alexander Melamed, Amy J Bregar, et al.
Contraception|November 6, 2012
Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine systemMelissa F Natavio, Deshawn Taylor, Radha A Lewis, et al.
Journal of Minimally Invasive Gynecology|November 17, 2020
The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysisAnne Knisely, Charlotte R Gamble, Caryn M St Clair, et al.
JAMA Network Open|January 9, 2024
Regional Variation in Antenatal Late Preterm Steroid Use Following the ALPS TrialTaylor S Freret, Jessica L Cohen, Cynthia Gyamfi-Bannerman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 25, 2021
Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancerAnna Greer, Allison Gockley, Beryl Manning-Geist, et al.
Plos One|September 21, 2019
Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation modelAnna P Lietz, Davis T Weaver, Alexander Melamed, et al.
Gynecologic Oncology|May 14, 2015
Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?Sue Yazaki Sun, Alexander Melamed, Donald P Goldstein, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 31, 2024
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with MedicareAnne Knisely, Chi-Fang Wu, Alexa Kanbergs, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 28, 2021
Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancerShayan Dioun, Ling Chen, Alexander Melamed, et al.
Pageof 22

Showing results (101-110 of 217) with videos related to

Sort By:
Pageof 22
Gynecologic Oncology|March 28, 2023
Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapyKirsten Jorgensen, Alexander Melamed, Chi-Fang Wu, et al.
Obstetrics and Gynecology|February 9, 2017
Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian CancerAllison Gockley, Alexander Melamed, Amy J Bregar, et al.
Contraception|November 6, 2012
Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine systemMelissa F Natavio, Deshawn Taylor, Radha A Lewis, et al.
Journal of Minimally Invasive Gynecology|November 17, 2020
The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysisAnne Knisely, Charlotte R Gamble, Caryn M St Clair, et al.
JAMA Network Open|January 9, 2024
Regional Variation in Antenatal Late Preterm Steroid Use Following the ALPS TrialTaylor S Freret, Jessica L Cohen, Cynthia Gyamfi-Bannerman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 25, 2021
Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancerAnna Greer, Allison Gockley, Beryl Manning-Geist, et al.
Plos One|September 21, 2019
Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation modelAnna P Lietz, Davis T Weaver, Alexander Melamed, et al.
Gynecologic Oncology|May 14, 2015
Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?Sue Yazaki Sun, Alexander Melamed, Donald P Goldstein, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 31, 2024
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with MedicareAnne Knisely, Chi-Fang Wu, Alexa Kanbergs, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 28, 2021
Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancerShayan Dioun, Ling Chen, Alexander Melamed, et al.
Pageof 22